Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]

Novakovic D, Feligioni M, Scaccianoce S, et al. Drug Des Devel Ther. 2013;7:1359–1364.On page 1362, left hand column, last sentence under Functional studies:The effects of gantenerumab on cognitive assessment in the Morris water maze test were inconclusive, as both wild-type and transgeni...

Full description

Bibliographic Details
Main Authors: Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, Nisticò R
Format: Article
Language:English
Published: Dove Medical Press 2014-05-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/corrigendum-profile-of-gantenerumab-and-its-potential-in-the-trea-peer-reviewed-article-DDDT